Term ends May 12, 2031 · High confidence
20-year base term ends Dec 6, 2030
Held by Bioverativ Therapeutics Inc.
Filed Mar 11, 2013 as application 13/793,783 · Granted Jan 26, 2016
Base term plus 157 days of patent term adjustment (USPTO delay)
Today
2010
2031
Clock starts
Dec 6, 2010
Dec 6, 2010
Term ends
May 12, 2031
May 12, 2031
Granted
Jan 26, 2016
Jan 26, 2016
base term
patent term adjustment
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
157
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 157 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 6, 2010, when application PCT/US2010/059136, the earliest non-provisional in its chain, was filed (this one was filed Mar 11, 2013) | Dec 6, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +157 days, USPTO patent term adjustment record | May 12, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 12, 2031 | High confidence |
This family
| Application PCT/US2010/059136 | PCT application no patent term | no patent term |
| US 9,050,318 | In force Apr 2031 | Apr 2031 |
| US 9,241,978 | this patent May 2031 | May 2031 |
| Application 14/964,289 | Abandoned not computed | not computed |
| US 11,266,720 | In force Apr 2031 | Apr 2031 |
| Application 17/587,941 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 6, 2013 Reel 31730, frame 449 | Dumont, Jennifer A.; Low, Susan; Bitonti, Alan J.; Pierce, Glenn; Luk, Alvin; Jiang, Haiyan; McKinney, Byron; Ottmer, Matt; Sommer, Jurg; Nugent, Karen; Li, Lian; Peters, Robert | Biogen Idec Hemophilia Inc. | Assignment of Assignor's Interest |
| Apr 30, 2015 Reel 35553, frame 325 | Biogen Idec Hemophilia Inc. | Biogen Hemophilia Inc. | Change of Name |
| Jul 2, 2015 Reel 36051, frame 773 | Biogen Hemophilia Inc. | Biogen Hemophilia Inc. | Change of Address |
| Feb 16, 2017 Reel 41735, frame 696 | Biogen Hemophilia Inc. | Bioverativ Therapeutics Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2031
Term ends May 12, 2031. Maintenance fees still fall due before then
Note
The 157 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
77
later US patents cite this one
That is top 5% of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.